# The Use of DPP-4 Inhibitors in Short Bowel Syndrome

> **NCT02653131** · PHASE4 · TERMINATED · sponsor: **Stanley Dudrick's Memorial Hospital** · enrollment: 8 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Dipeptidyl peptidase-4 inhibitor

## Key facts

- **NCT ID:** NCT02653131
- **Lead sponsor:** Stanley Dudrick's Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** too many side-effects
- **Last updated:** 2020-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02653131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02653131, "The Use of DPP-4 Inhibitors in Short Bowel Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02653131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*